Amarin Corp Plc (AMRN)

[couldbebetter]

I think HDGabor was just being "flippant" with his reply.
Obviously, an immediate swift price adjustment if AMRN lost the trial.
but I still would believe that Europe would be worth more than what
US (would have been.) Even with the US "gone"I believe that Europe
could be 3 million patients and at $2000 a year would mean $6
billion a year in peak revenues making Europe worth $24 billion.
Sounds implausible, but I believe those numbers are realistic.

Actually, If Judge Du gave the generics a win...that would set up
AMRN for the best buy point since it was under a dollar.